» Articles » PMID: 26446471

Recent Advances in the Fundamental Understanding of Adhesive Mixtures for Inhalation

Overview
Journal Curr Pharm Des
Date 2015 Oct 9
PMID 26446471
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Adhesive mixtures for inhalation are the most widely used type of formulation in dry powder inhalation products. Although they have been the subject of active research, the relationships between properties of the starting materials, the mixing and dispersion processes, and the dispersion performance of this type of formulation are generally poorly understood. Interactions between relevant variables have been mentioned as an important cause. By reviewing the effects on mixture dispersion performance of the most widely studied formulation variables we try to find out whether or not the understanding of adhesive mixtures has improved in recent years. We furthermore propose an approach that may potentially accelerate the process of understanding. General conclusions concerning the effects of the variables considered cannot be drawn, because inconsistent findings are reported throughout the literature for all of them. These inconsistencies are indeed largely the result of interactions between variables of the formulation and dispersion processes. Mechanisms for most of the observed effects and interactions have been proposed, but they often remain unproven and, therefore, speculative. We have attempted to condense the knowledge from the literature into a theoretical framework that is intended to help explain the interplay between variables. According to this framework, only few mixture properties are key to understanding the effects of and interactions between formulation variables. Therefore, we suggest that the development or optimisation of techniques to accurately characterise these mixture properties could be an effective approach to further the fundamental understanding of adhesive mixtures for inhalation and enable their rational engineering.

Citing Articles

Feasibility of a High-Dose Inhaled Indomethacin Dry Powder with Dual Deposition for Pulmonary and Oral Delivery.

Spahn J, Hefnawy A, Zhang F, Smyth H Pharmaceutics. 2024; 16(10).

PMID: 39458601 PMC: 11510369. DOI: 10.3390/pharmaceutics16101269.


Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements.

Magramane S, Vlahovic K, Gordon P, Kallai-Szabo N, Zelko R, Antal I Pharmaceuticals (Basel). 2023; 16(12).

PMID: 38139785 PMC: 10747137. DOI: 10.3390/ph16121658.


Spray-Congealing and Wet-Sieving as Alternative Processes for Engineering of Inhalation Carrier Particles: Comparison of Surface Properties, Blending and In Vitro Performance.

Pinto J, Zellnitz S, Guidi T, Schiaretti F, Schroettner H, Paudel A Pharm Res. 2021; 38(6):1107-1123.

PMID: 34114162 PMC: 8217042. DOI: 10.1007/s11095-021-03061-5.


On the relationship between blend state and dispersibility of adhesive mixtures containing active pharmaceutical ingredients.

Ruden J, Frenning G, Bramer T, Thalberg K, Alderborn G Int J Pharm X. 2021; 3:100069.

PMID: 33409485 PMC: 7773864. DOI: 10.1016/j.ijpx.2020.100069.


Novel approach for real-time monitoring of carrier-based DPIs delivery process pulmonary route based on modular modified Sympatec HELOS.

Zhang X, Cui Y, Liang R, Wang G, Yue X, Zhao Z Acta Pharm Sin B. 2020; 10(7):1331-1346.

PMID: 32874832 PMC: 7452036. DOI: 10.1016/j.apsb.2020.02.013.